Try the Free App:
Prime PubMed app for iOS iPhone iPad
Prime PubMed app for Android
Prime PubMed is provided
free to individuals by:
Unbound Medicine.
(Apri)
2,000 results
  • Non-invasive fibrosis markers for assessment of liver fibrosis in chronic hepatitis delta. [Journal Article]
    J Viral Hepat. 2023 Jan 18 [Online ahead of print]Kalkan Ç, Yılmaz Y, … Yurdaydin C
  • Assessment of liver fibrosis by non-invasive means is clinically important studies in chronic hepatitis delta (CHD) are scarce.To evaluate performance of eight serum fibrosis markers [fibrosis-4 score (FIB-4), aspartate aminotransferase (AST) to alanine aminotransferase (ALT) ratio (AAR), age-platelet index (API), AST-to platelet-ratio-index (APRI), Goteborg University Cirrhosis Index (GUCI), Lok…
  • [A study on the diagnostic value of GP73 in liver fibrosis among patients with chronic liver disease]. [Journal Article]
    Zhonghua Nei Ke Za Zhi. 2023 Jan 01; 62(1):49-53.An XY, Qiao J, … Nan YM
  • Objective: This study aimed to evaluate the diagnostic value of serum Golgi protein 73(GP73) alone and GP73 combined with liver stiffness measurement (LSM), aspartate aminotransferase/platelet ratio index (APRI), and 4-factor-based fibrosis index (FIB4) in diagnosing liver fibrosis in patients with chronic liver disease of different etiologies. Methods: A diagnostic test. A total of 68 patients w…
New Search Next